Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer (NCT07492927)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (10 Sites)

• Northwestern Memorial Hospital — Chicago, Illinois
• The First Hospital of Lanzhou University — Lanzhou, Gansu
• General Hospital of Ningxia Medical University — Yinchuan, Ningxia
• Qinghai University Affiliated Hospital — Xining, Qinghai
• Weinan Central Hospital — Weinan, Shaanxi
• Shaanxi Provincial People's Hospital — Xi'an, Shaanxi
• Xijing 986 Hospital — Xi'an, Shaanxi
• The Second Affiliated Hospital of Shaanxi University of Chinese Medicine — Xianyang, Shaanxi
• Yan'an University Affiliated Hospital — Yan’an, Shaanxi
• Xijing Hospital — Xi'an,

📞 Contact the Study Coordinator

Phone: +86 029 84771062

Email: 1531769428@qq.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Clinically Significant Prostate Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.